Latest "Fluorouracil Leukovorin bevacizumab Colorectal Cancer" News Stories

18:42 EST 1st December 2015 | BioPortfolio

Here are the most relevant search results for "Fluorouracil Leukovorin bevacizumab Colorectal Cancer" found in our extensive news archives from over 250 global news sources.

More Information about Fluorouracil Leukovorin bevacizumab Colorectal Cancer on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Fluorouracil Leukovorin bevacizumab Colorectal Cancer for you to read. Along with our medical data and news we also list Fluorouracil Leukovorin bevacizumab Colorectal Cancer Clinical Trials, which are updated daily. BioPortfolio also has a large database of Fluorouracil Leukovorin bevacizumab Colorectal Cancer Companies for you to search.

Showing "Fluorouracil Leukovorin bevacizumab Colorectal Cancer" News Articles 1–25 of 16,000+

Extremely Relevant

Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer

Global Colorectal Cancer Drugs Market 2015-2019

About Colorectal Cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in th...

Add panitumumab or bevacizumab to improve first-line metastatic colorectal cancer therapy?

Dr Rivera talks to ecancertv at ECC 2015 about the final analysis of the PEAK randomized phase II study in patients with metastatic colorectal cancer and ways of improving upon current therapy. The primary endpoint was progression-free survival, wh...

Lonsurf® Approved for the Treatment of Colorectal Cancer

The United States Food and Drug Administration (FDA) has approved the oral agent, Lonsurf® (trifluridine and tipiracil), for the treatment of colorectal cancer. Colorectal cancer remains the second leading cause of cancer-related deaths in the U.S. ...


Colorectal cancer: An intravenous probe for colorectal cancer screening

Early detection of colorectal lesions is the cornerstone of cancer prevention. Intravenous administration of a novel fluorescent peptide probe now enables the screening of the whole colorectal area using near-infrared fluorescence colonoscopy, an app...

New approach holds promise for earlier, easier detection of colorectal cancer

(California Institute of Technology) Chemists at Caltech have developed a new sensitive electrochemical technique capable of detecting colorectal cancer in tissue samples -- a method that could one day be used in clinical settings for the early diagn...

Effects of aspirin on colorectal cancer

In this interview Dr Din, a Cancer Research UK Clinician Scientist and Honorary Consultant Colorectal Surgeon, discusses her work looking at the use of aspirin as a chemopreventative agent in colorectal cancer (CRC) at the 2015 Scientific Conference ...

Recent Increase in Colorectal Cancer

The Fall 2015 issue of Cancer Today, a publication of the American Association for Cancer Research (AACR), features "Colorectal Cancer: A Troubling Trend."  Colorectal cancer diagnoses are on the rise among adults under age 50, lower than the recommended age to begin regular screening. Published quarterly by the AACR, Cancer Today is an authoritative resource for cancer patients, survivors, ...

Advances in the care of patients with mucinous colorectal cancer

Mucinous colorectal cancer has, in the past, been associated with inferior responses to treatment, and worse patient outcomes compared with other colorectal cancer subtypes; although, this situation has improved in the past 10–15 years. In this Rev...

Adding Bevacizumab to Chemotherapy Improves PFS in Endometrial Cancer

The addition of bevacizumab to carboplatin/paclitaxel chemotherapy increases progression-free survival in advanced/recurrent endometrial cancer patients.

Researchers examine risk factors/patient outcomes associated with colorectal cancer

About 20 percent of colorectal cancer patients have cancers that have spread beyond the colon at the time of their diagnosis. In a new study, researchers provide a detailed comparison of patient outcomes associated with synchronous and sequential col...

Neoadjuvant Bevacizumab May Benefit Subset of Breast Cancer Patients

Preoperative bevacizumab may predominantly benefit breast cancer patients with a high baseline microvessel density, according to a new study.

The consensus molecular subtypes of colorectal cancer

An international consortium of colorectal cancer researchers undertakes a large-scale data sharing project to achieve a consensus molecular classification of colorectal cancers.

Patients with lowest BMI have shortest survival in pooled analysis of bev in mCRC

(European Society for Medical Oncology) Patients with the lowest body mass index had the shortest overall survival in an analysis of bevacizumab studies in metastatic colorectal cancer presented for the first time at the ESMO 17th World Congress on G...

Research points to why some colorectal cancers recur after treatment

(University of Texas M. D. Anderson Cancer Center) Cetuximab, marketed as Erbitux, is one of the key therapies for metastatic colorectal cancer. Yet the cancer still returns in some patients, shortening overall survival.

Researcher calls for changes to colorectal cancer screening guidelines

(University of Pennsylvania School of Medicine) Colorectal cancer will claim the lives of close to 50,000 Americans this year, according to the American Cancer Society. Screening is the most effective way to reduce the risk of dying from the disease,...

Neoadjuvant Bevacizumab Shows Promise in HER2-Negative Breast Cancer

A phase III trial demonstrated efficacy and safety of adding bevacizumab (Avastin) to standard neoadjuvant chemotherapy in patients with HER2-negative breast cancer.

ECC 2015: Discovery of differences between tumours of younger and older colorectal cancer patients may lead to better treatments

Colorectal cancer (CRC) is on the rise among younger patients. Although some of the younger-onset cases can be explained by hereditary factors, the majority arise spontaneously. Researchers have now found that tumours in younger colorectal cancer.....

Mouse models of human colorectal cancer generated through chemokine targeting

by ecancer reporter Clare Sansom Xenografts of human colorectal cancer (CRC) cells into mouse models have yielded many important insights into the pathogenesis of this disease and its treatment. However, none of the mouse models of colorectal canc...

Does Processed Meat Cause Colorectal Cancer?

According to the International Agency for Research on Cancer (IARC), eating processed meat products can increase a person’s risk for developing colorectal cancer. Processed meat is classified as meat that has been salted, cured, fermented, or smoke...

Teva Recalls Six More Lots of Fluorouracil Injection

The recall of Adrucil is due to the potential presence of particulate matter identified as an aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals. News Alerts

Researchers discover component of cinnamon prevents colorectal cancer in mice

Research conducted at the University of Arizona College of Pharmacy and the UA Cancer Center indicates that a compound derived from cinnamon is a potent inhibitor of colorectal cancer.

Low BMI Linked to Poorer Survival in Colorectal Cancer

A new study has found that in patients diagnosed with metastatic colorectal cancer, a low BMI could be a poor prognostic factor.

AGA recommends all patients with colorectal cancer get tested for Lynch syndrome

(American Gastroenterological Association) All colorectal cancer patients should undergo tumor testing to see if they carry Lynch syndrome, the most common inherited cause of colorectal cancer, according to a new guideline was published in Gastroente...

Virtual Colonoscopy now available in screening for colorectal cancer at Frisbie Memorial Hospital

ROCHESTER, N.H., June 4, 2015 /PRNewswire/ -- Frisbie Memorial Hospital is now using low-dose CT scanning as a follow-up tool for screening colorectal cancer. This procedure, known as virtual colonoscopy, does not replace the effective and most reliable colorectal cancer screening tool, which is the colonoscopy, but rather it is utilized as a means to obtain additional images of the colon and rect...


News Quicklinks